These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6969450)

  • 41. The effect of iron on metronidazole activity against Trichomonas vaginalis in vitro.
    Elwakil HS; Tawfik RA; Alam-Eldin YH; Nassar DA
    Exp Parasitol; 2017 Nov; 182():34-36. PubMed ID: 28935536
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Susceptibility in vitro of clinically metronidazole-resistant Trichomonas vaginalis to nitazoxanide, toyocamycin, and 2-fluoro-2'-deoxyadenosine.
    Wright JM; Dunn LA; Kazimierczuk Z; Burgess AG; Krauer KG; Upcroft P; Upcroft JA
    Parasitol Res; 2010 Sep; 107(4):847-53. PubMed ID: 20532912
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metronidazole inhibition of hydrogen production in vivo in drug-sensitive and resistant strains of Trichomonas vaginalis.
    Lloyd D; Kristensen B
    J Gen Microbiol; 1985 Apr; 131(4):849-53. PubMed ID: 3921658
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A metronidazole-resistant strain of Trichomonas vaginalis and its sensitivity to Go 10213.
    Ray DK; Tendulkar JS; Shrivastava VB; Datta AK; Nagarajan K
    J Antimicrob Chemother; 1984 Oct; 14(4):423-6. PubMed ID: 6334072
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Drug library screening against metronidazole-sensitive and metronidazole-resistant Trichomonas vaginalis isolates.
    Goodhew EB; Secor WE
    Sex Transm Infect; 2013 Sep; 89(6):479-84. PubMed ID: 23794105
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metronidazole-resistant clinical isolates of Trichomonas vaginalis have lowered oxygen affinities.
    Yarlett N; Yarlett NC; Lloyd D
    Mol Biochem Parasitol; 1986 May; 19(2):111-6. PubMed ID: 3487729
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metronidazole-resistant Trichomonas vaginalis.
    Forsgren A; Forssman L
    Br J Vener Dis; 1979 Oct; 55(5):351-3. PubMed ID: 315809
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Drug susceptibility testing of anaerobic protozoa.
    Upcroft JA; Upcroft P
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1810-4. PubMed ID: 11353630
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro activity of nitazoxanide against some metronidazole-resistant and susceptible Trichomonas vaginalis isolates.
    Abdel-Magied AA; Hammouda MM; Mosbah A; El-Henawy AA
    J Infect Chemother; 2017 Apr; 23(4):230-233. PubMed ID: 28131737
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of metronidazole-resistant Trichomonas vaginalis in a gynecology clinic.
    Schmid G; Narcisi E; Mosure D; Secor WE; Higgins J; Moreno H
    J Reprod Med; 2001 Jun; 46(6):545-9. PubMed ID: 11441678
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacodynamics of metronidazole determined by a time-kill assay for Trichomonas vaginalis.
    Nix DE; Tyrrell R; Müller M
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1848-52. PubMed ID: 7486930
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sensitivity of Trichomonas vaginalis to metronidazole, tinidazole, and nifuratel in vitro.
    Korner B; Jensen HK
    Br J Vener Dis; 1976 Dec; 52(6):404-8. PubMed ID: 1087577
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The genetic diversity of metronidazole susceptibility in Trichomonas vaginalis clinical isolates in an Egyptian population.
    Abdel-Magied AA; El-Kholya EI; Abou El-Khair SM; Abdelmegeed ES; Hamoudaa MM; Mohamed SA; El-Tantawy NL
    Parasitol Res; 2017 Nov; 116(11):3125-3130. PubMed ID: 28956167
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population.
    Krashin JW; Koumans EH; Bradshaw-Sydnor AC; Braxton JR; Evan Secor W; Sawyer MK; Markowitz LE
    Sex Transm Dis; 2010 Jul; 37(7):440-4. PubMed ID: 20351623
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reduction of niridazole by metronidazole resistant and susceptible strains of Trichomonas vaginalis.
    Yarlett N; Rowlands CC; Yarlett NC; Evans JC; Lloyd D
    Parasitology; 1987 Feb; 94 ( Pt 1)():93-9. PubMed ID: 3029651
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    Ghosh AP; Aycock C; Schwebke JR
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29439963
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-Trichomonas vaginalis activity of ursolic acid derivative: a promising alternative.
    Bitencourt FG; de Brum Vieira P; Meirelles LC; Rigo GV; da Silva EF; Gnoatto SCB; Tasca T
    Parasitol Res; 2018 May; 117(5):1573-1580. PubMed ID: 29572567
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Role of Iron Status in the Early Progression of Metronidazole Resistance in Trichomonas vaginalis Under Microaerophilic Conditions.
    Argáez-Correa W; Alvarez-Sánchez ME; Arana-Argáez VE; Ramírez-Camacho MA; Novelo-Castilla JS; Coral-Martínez TI; Torres-Romero JC
    J Eukaryot Microbiol; 2019 Mar; 66(2):309-315. PubMed ID: 30047563
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An in vitro metronidazole susceptibility test for trichomoniasis using the InPouch TV test.
    Borchardt KA; Li Z; Zhang MZ; Shing H
    Genitourin Med; 1996 Apr; 72(2):132-5. PubMed ID: 8698362
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hydrogenosomes of laboratory-induced metronidazole-resistant Trichomonas vaginalis lines are downsized while those from clinically metronidazole-resistant isolates are not.
    Wright JM; Webb RI; O'Donoghue P; Upcroft P; Upcroft JA
    J Eukaryot Microbiol; 2010; 57(2):171-6. PubMed ID: 20015182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.